Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab–bendamustine in follicular lymphoma: a single-center case series study
2025 · Journal of Cancer Research and Clinical Oncology · 0 citations
https://doi.org/10.1007/s00432-025-06351-2